Open AccessA new Korean Research Investment for Global Health Technology (RIGHT) Fund to advance innovative neglected-disease technologies
Author(s) -
Peter J. Hotez,
Kim Bush,
Andrin Oswald,
Glenn Rockman,
In-taek Lim,
Youngmee Jee,
Chang Jin Moon,
Jerome H. Kim,
Younbeen Kim
Publication year - 2020
Publication title -
plos neglected tropical diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.99
H-Index - 135
eISSN - 1935-2735
pISSN - 1935-2727
DOI - 10.1371/journal.pntd.0007956
Subject(s) - agency (philosophy) , government (linguistics) , investment (military) , economic growth , funding agency , business , venture capital , health technology , political science , finance , health care , public relations , economics , politics , sociology , linguistics , philosophy , law , social science
In 2018, the government of the Republic of Korea (ROK), South Korean life science companies, and a group of international funders led by the Bill & Melinda Gates Foundation launched a new and innovative funding agency to support neglected-disease research and development (R&D). The new venture is known as the Research Investment for Global Health Technology (RIGHT) Fund.